Previously, we reported that LD IL-2 may be an effective therapy to treat IBD based on our results whereby LD IL-2 induced human Treg cell expansion and attenuated experimental colitis in immune humanized NSG mice expressing human HLA-DQ8 in a setting devoid of murine MHCII (28). Here, IL2 is linked to colitis.